|
1
|
McPhee C, Yevdokimova K, Rogers L, Kraft M. The SARS-CoV-2 pandemic and asthma: What we have learned and what is still unknown. J Allergy Clin Immunol 2023; 152:1376-1381. [PMID: 37739069 DOI: 10.1016/j.jaci.2023.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 09/01/2023] [Accepted: 09/15/2023] [Indexed: 09/24/2023]
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought new insights into the immunologic intricacies of asthma. In this review, we discuss the epidemiology of asthma in patients infected with SARS-CoV-2 and the risk of severe infection. Type 2 inflammation had an overall protective effect against SARS-CoV-2 infection by various mechanisms summarized in this review. Asthma, intranasal, and inhaled corticosteroids decreased the angiotensin-converting enzyme 2 receptor, an important receptor for SARS-CoV-2 entry into host cells. We summarize the nuances of the treatment of type 2 inflammation despite its underlying protective effects. Research to date has shown that patients on various allergen immunotherapies and biologics do benefit from being vaccinated.
Collapse
Affiliation(s)
- Christa McPhee
- Division of Pulmonary, Critical Care and Sleep Medicine, Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
| | - Kateryna Yevdokimova
- Division of Pulmonary, Critical Care and Sleep Medicine, Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Linda Rogers
- Division of Pulmonary, Critical Care and Sleep Medicine, Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Monica Kraft
- Division of Pulmonary, Critical Care and Sleep Medicine, Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| |
Collapse
|
|
2
|
Cheng H, Narzo AD, Howell D, Yevdokimova K, Zhang J, Zhang X, Pan Q, Zhang Z, Rogers L, Hao K. Ambient Air Pollutants and Traffic Factors Were Associated with Blood and Urine Biomarkers and Asthma Risk. Environ Sci Technol 2022; 56:7298-7307. [PMID: 35239329 DOI: 10.1021/acs.est.1c06916] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
The UK Biobank (UKBB) is a large population-based cohort that provides a unique opportunity to study the association between environmental exposure and biomarkers and to identify biomarkers as potential instruments for assessing exposure dose, health damage, and disease risks. On 462 063 participants of European ancestry, we characterized the relationship of 38 disease-relevant biomarkers, asthma diagnosis, ambient pollution, traffic factors, and genetic background. The air pollutant exposure on the UKBB cohort was fairly low (e.g., mean PM2.5 concentration at 10.0 μg/m3). Nevertheless, 30 biomarkers were in association with at least one environmental factor; e.g., C-reactive protein levels were positively associated with NO (padj = 2.99 × 10-4), NO2 (padj = 4.15 × 10-4), and PM2.5 (padj = 1.92 × 10-6) even after multiple testing adjustment. Asthma diagnosis was associated with four pollutants (NO, NO2, PM2.5, and PM10). The largest effect size was observed in PM2.5, where a 5 μg/m3 increment of exposure was associated with a 1.52 increase in asthma diagnosis (p = 4.41 × 10-13). Further, environmental exposure and genetic predisposition influenced biomarker levels and asthma diagnosis in an additive model. The exposure-biomarker associations identified in this study could serve as potential indicators for environmental exposure induced health damages. Our results also shed light on possible mechanisms whereby environmental exposure influences disease-causing biomarkers and in turn increases disease risk.
Collapse
Affiliation(s)
- Haoxiang Cheng
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
| | | | - Daniel Howell
- Division of Pulmonary Critical Care, Woodhull Hospital, New York University, New York, New York 11206, United States
| | - Kateryna Yevdokimova
- Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
| | - Jushan Zhang
- Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China
- College of Environmental Science and Engineering, Tongji University, Shanghai, 200092, China
| | | | - Qi Pan
- Sema4, Stamford, Connecticut 06902, United States
| | - Zhongyang Zhang
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
| | - Linda Rogers
- Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
| | - Ke Hao
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
- Sema4, Stamford, Connecticut 06902, United States
| |
Collapse
|
|
3
|
Dhande M, Rideout JM, Yevdokimova K, DiDomenico D, Chweich H, Rencic J, Huggins G. I(CA)RAMBO: A MNEMONIC THAT IMPROVES GUIDELINE ADHERENCE IN CARDIAC RESUSCITATION. J Am Coll Cardiol 2020. [DOI: 10.1016/s0735-1097(20)34144-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|